Physician profile
Timmy Lahm
NPI 1447426382
$25,832.20
in general payments reported to CMS, 2019-2025
6 companies · $500 in 2025
The $500 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,519 · 2020: $6,950 · 2021: $9,077 · 2022: $590 · 2023: $197 · 2025: $500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $697.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $697.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $19,611.99 | 2019-2022 | |
| United Therapeutics Corporation | $5,204.11 | 2019-2025 | Tyvaso |
| Actelion Pharmaceuticals US, INC. | $625.47 | 2021-2023 | Uptravi |
| Genentech USA, INC. | $149.71 | 2022 | |
| Agepha Pharma Fz LLC | $135.44 | 2025 | Lodoco |
| Astrazeneca Pharmaceuticals LP | $105.48 | 2023 | Fasenra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timmy Lahm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.